DRUG APPROVED FOR INOPERABLE MELANOMA

Keytruda (pembrolizumab) was finally approved for the treatment of inoperable malignant melanoma. Testing was never completed as it performed so well in the early clinical trials.

Robert S. Bader, M.D., Dermatologist

Recent Posts

Categories

Subscribe!